ישראל - עברית - Ministry of Health

teva israel ltd - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 20 mg/ml - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 20 mg/dose - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 104 mg / 0.65 ml - medroxyprogesterone - medroxyprogesterone - * sayana is indicated for long-term female contraception. each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). however, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .since loss of bone mineral density may occur in females of all ages who use sayana long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* use in adolescents (12-18 years)in adolescents, use of sayana is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with sayana during the critical period of bone accretion.sayana has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.

ישראל - עברית - Ministry of Health

teva israel ltd - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 40 mg - glatiramer acetate

ישראל - עברית - Ministry of Health

teva israel ltd - glatiramer acetate - תמיסה להזרקה - glatiramer acetate 40 mg - glatiramer acetate

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - gonadorelin as acetate - תמיסה להזרקה - gonadorelin as acetate 50 mcg/ml

ישראל - עברית - Ministry of Health

taro international ltd, israel - triamcinolone acetonide - פסטה - triamcinolone acetonide 0.1 % - triamcinolone - triamcinolone - indicated for the adjunctive treatment and the temporary relief of symptoms associated with oral inflammatory and ulcerative lesions.

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - lidocaine hydrochloride monohydrate; triamcinolone acetonide - פסטה - lidocaine hydrochloride monohydrate 3 g / 100 g; triamcinolone acetonide 0.1 g / 100 g - triamcinolone - triamcinolone - adjunctive treatment and temporary relief of symptoms associated with inflammatory lesions in the oral cavity.

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - משחה - triamcinolone acetonide 1 mg/g; neomycin as sulfate 2.5 mg/g; gramicidin 0.25 mg/g; nystatin 100000 iu/g - triamcinolone and antibiotics - triamcinolone and antibiotics - antifungal, antibacterial

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - קרם - nystatin 100000 iu/g; gramicidin 0.25 mg/g; neomycin as sulfate 2.5 mg/g; triamcinolone acetonide 1 mg/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for local treatment of skin inflammations accompanied with mycotic and/or bacterial infection.